SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0000891293-18-000034
Filing Date
2018-01-31
Accepted
2018-01-31 16:16:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 POS AM cti_-xsx3xpostxeffectivexa.htm POS AM 631184
2 ommus76070686v3ctis3pimage.jpg GRAPHIC 2758
  Complete submission text file 0000891293-18-000034.txt   636213
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-221382 | Film No.: 18562929
SIC: 2834 Pharmaceutical Preparations